van Lint, Jette A. https://orcid.org/0000-0003-2303-6199
Jessurun, Naomi T.
Tas, Sander W.
Vonkeman, Harald E.
van Doorn, Martijn B. A.
Hoentjen, Frank
Nurmohamed, Michael T.
van Puijenbroek, Eugene P.
van den Bemt, Bart J. F.
Funding for this research was provided by:
ZonMw (848050005)
Article History
Accepted: 1 March 2023
First Online: 3 April 2023
Declarations
:
: Jette van Lint, Naomi Jessurun, Michael Nurmohamed, Bart van den Bemt and Eugene van Puijenbroek declare no conflicts of interest. Sander Tas reports grants and/or personal fees from Abbvie, Arthrogen, AstraZeneca, BMS, Celgene, Galapagos, GSK, MSD, Pfizer, Roche, and Sanofi-Genzyme, all outside the submitted work. Frank Hoentjen has served on advisory boards, or as speaker or consultant for Abbvie, Celgene, Janssen-Cilag, MSD, Takeda, Celltrion, Teva, Sandoz, and Dr Falk; and has received unrestricted grants from Dr Falk, Janssen-Cilag, and Abbvie. Martijn van Doorn has received consulting fees or honorarium from Novartis, Abbvie, Pfizer, Leopharma, Sanofi, Lilly, Janssen, Celgene, and BMS; has received a grant and payment for lectures, including service on speakers bureaus, from Novartis, Sanofi, and Janssen, outside the submitted work. Harald Vonkeman reports grants and/or personal fees from AbbVie, Amgen, AstraZeneca, BMS, Celgene, Celltrion, Galapagos, Gilead, GSK, Janssen-Cilag, Lilly, MSD, Novartis, Pfizer, Roche, Sanofi-Genzyme, and UCB, all outside the submitted work.
: The Dutch Biologic Monitor work was supported by the Netherlands Organisation for Health Research and Development (ZonMw) [grant number 848050005]. No funding was received for this study.
: JvL, NJ, and BvdB contributed to the conception and design of this study. JvL and NJ contributed to the analysis and interpretation of the data and drafting of the paper. BvdB, ST, MvD, MN, EvP, FH, and HV critically revised the paper for intellectual content. All authors approved the final version and agree to be accountable for all aspects of this work.
: Ethical approval of the Dutch Biologic Monitor was waived for the Dutch Medical Research Involving Human Subjects Act (WMO) by the Medical Research Ethical Committee of Brabant, The Netherlands (NW2016-66).
: The datasets generated and/or analysed during the current study are not publicly available due to privacy but are available from the corresponding author on reasonable request.
: All participants received information about the Dutch Biologic Monitor prior to participation and signed a digital informed consent form.
: Not applicable.
: Not applicable.